- Home
- CMBM vs TRIB Comparison
CMBM vs TRIB Comparison
Compare CMBM & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- TRIB
- Stock Information
- Founded
- CMBM 2011
- TRIB 1992
- Country
- CMBM United States
- TRIB Ireland
- Employees
- CMBM N/A
- TRIB N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CMBM Technology
- TRIB Health Care
- Exchange
- CMBM Nasdaq
- TRIB Nasdaq
- Market Cap
- CMBM 26.5M
- TRIB 24.0M
- IPO Year
- CMBM 2019
- TRIB N/A
- Fundamental
- Price
- CMBM $0.70
- TRIB $0.81
- Analyst Decision
- CMBM Strong Buy
- TRIB
- Analyst Count
- CMBM 3
- TRIB 0
- Target Price
- CMBM $5.50
- TRIB N/A
- AVG Volume (30 Days)
- CMBM 144.6K
- TRIB 147.6K
- Earning Date
- CMBM 11-07-2024
- TRIB 11-15-2024
- Dividend Yield
- CMBM N/A
- TRIB N/A
- EPS Growth
- CMBM N/A
- TRIB N/A
- EPS
- CMBM N/A
- TRIB N/A
- Revenue
- CMBM $172,215,000.00
- TRIB $59,126,000.00
- Revenue This Year
- CMBM N/A
- TRIB $11.63
- Revenue Next Year
- CMBM $16.49
- TRIB $10.13
- P/E Ratio
- CMBM N/A
- TRIB N/A
- Revenue Growth
- CMBM N/A
- TRIB N/A
- 52 Week Low
- CMBM $0.66
- TRIB $0.75
- 52 Week High
- CMBM $6.50
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- CMBM 26.27
- TRIB 25.82
- Support Level
- CMBM $0.66
- TRIB $0.75
- Resistance Level
- CMBM $1.25
- TRIB $0.93
- Average True Range (ATR)
- CMBM 0.11
- TRIB 0.11
- MACD
- CMBM -0.04
- TRIB 0.00
- Stochastic Oscillator
- CMBM 6.79
- TRIB 13.00
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.